|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/28 | (2006.01) |
| C07K 14/70 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 5/16 | (2006.01) | ||
| A61P 5/38 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 21/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 3431492 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18169942.2 |
| Date of filing the European patent application | 2013-04-25 | |
| (97) | Date of publication of the European application | 2019-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation | 2021-04-26 |
| (30) | Number | Date | Country code |
| 201261639637 P | 2012-04-27 | US |
| (72) |
ANDERSEN, Mette Dahl, DK
DANTZLER, Jeff, US
ARMITAGE, Richard J., US
CLARK, Rutilio, US
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus CD30 ligandą-antigeną surišantys baltymai |
| HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 14 | 289.00 EUR |
| 2027-04-25 |